Manjari Regmi

Dr. Manjari Regmi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in Clinical Medicine & Research
Verified
Journal Article
Closed access
PDF file
MRManjari Regmi
Manjari Regmi
NTNitin Tandan
Nitin Tandan
PPPriyanka Parajuli
Priyanka Parajuli
MBMukul Bhattarai
Mukul Bhattarai
RMRuby Maini
Ruby Maini
RRRobert Robinson
Robert Robinson
Objectives: The objective of our study was to use the parameters of social vulnerability index (SVI) to observe their association with the 30-day hospital readmissions in the heart failure population.

20 May 2020 in Medicines
Verified
Journal Article
Open access
PDF file
PPPriyanka Parajuli
Priyanka Parajuli
OLOdalys Estefania Lara-Garcia
Odalys Estefania Lara-Garcia
MRManjari Regmi
Manjari Regmi
WSWarren Skoza
Warren Skoza
MBMukul Bhattarai
Mukul Bhattarai
RRRobert Leonard Robinson
Robert Leonard Robinson
Background: The pharmacologic management of heart failure with preserved ejection fraction (HFpEF) involves far fewer options with demonstrated additional benefit. Therefore, we examined the effect of combination of multiple classes of HF medication in the 30-day hospital readmission in patients with HFpEF. Methods: All adult patients discharged with a diagnosis of HFpEF and a left ventricular ejection fraction (LVEF) of ≥ 50% reported during the admission or within the previous six months from our institution were retrospectively studied for a 30-day hospital readmission risk. Individual as well as combination drug therapy at the time of hospital discharge were evaluated using Pearson chi2 test and multivariate logistic regression. Results: The overall 30-day readmission rate in this HFpEF cohort of 445 discharges was 29%. Therapy with loop diuretics (p = 0.011), loop diuretics and angiotensin receptor blocker (p = 0.043) and loop diuretics and beta blockers (p = 0.049) were associated with a lower risk of 30-day hospital readmission. Multivariate logistic regression revealed only loop diuretics to be associated with a lower risk of hospital readmission in patients with HFpEF (OR 0.59; 95% CI, 0.39-0.90; p = 0.013). Conclusions: Our study revealed that loop diuretics at discharge decreases early readmission in patients with HFpEF. Further, our study highlights the implication of a lack of guidelines and treatment challenges in HFpEF patients and emphasizes the importance of a conservative approach in preventing early readmission in patients with HFpEF.

2 July 2019 in Cureus
Verified
Journal Article
Open access
PDF file
PPPriyanka Parajuli
Priyanka Parajuli
AIAbdisamad M. Ibrahim
Abdisamad M. Ibrahim
HSHarris H. Siddiqui
Harris H. Siddiqui
OGOdalys Estefania Lara Garcia
Odalys Estefania Lara Garcia
MRManjari Regmi
Manjari Regmi
Trimethoprim-sulfamethoxazole (TMP-SMX) is a bacteriostatic antimicrobial medication used for the treatment of a variety of infections and has many reported skin and hematologic side effects. Due to the easy availability and cost effectiveness, TMP-SMX is one of the medications commonly used for treatment of skin and soft tissue in patients with methicillin-resistant Staphylococcus aureus (MRSA) infection. One of the rare hematologic manifestations of TMP-SMX is pancytopenia, which is a reduction in all cell lines. In this case report, we are documenting a case of pancytopenia due to severe drug reaction to TMP-SMX in a 70-year-old female after two weeks of medication use. Upon initial stabilization she underwent a thorough workup and was subsequently diagnosed with severe drug-induced pancytopenia. Detailed history, early diagnosis, prompt discontinuation of the offending medication along with supportive care remain the mainstay of treatment in the management of TMP-SMX induced pancytopenia.

1 May 2023 in Current Cardiology Reviews
Verified
Journal Article
Closed access
PDF file
MRManjari Regmi
Manjari Regmi
MBMukul Bhattarai
Mukul Bhattarai
PPPriyanka Parajuli
Priyanka Parajuli
ABAlbert Botchway
Albert Botchway
NTNitin Tandan
Nitin Tandan
MLMohamed Labedi
Mohamed Labedi
Objectives: This meta-analysis aims to investigate the recurrence of atrial fibrillation (AF) post-ablation based on the various stages of fibrosis seen in the late gadolinium enhancement magnetic resonance imaging (LGE-MRI). Methods: Electronic databases were searched using specific terms and identified nine studies that met the inclusion criteria. A total of 1,787 patients underwent LGE-MRI to assess atrial fibrosis before catheter ablation for AF. We performed three analyses: first, we compared stage IV versus stage I (reference group). The second set examined the combined stages III and IV versus stages I and II (reference group). The third set compared stage IV versus combined stages I, II, and III. The metanalysis relied on a random-effects model to pool the odds ratios (OR) and 95% confidence intervals (CI) using the DerSimonian and Laird method. The data was analyzed using StatsDirect software in England. Results: The study showed a higher rate of AF recurrence after ablation in stage IV atrial fibrosis than in stage I (OR, 9.54; 95% CI, 3.81 to 28.89; P<00001). Also, in patients with combined stages III & IV of atrial fibrosis, AF recurrence was significantly higher after ablation than in stages I & II groups (OR, 2.37; 95% CI, 1.61 to 3.50; P<00001). Similarly, compared to combined stages I, II, and III, patients with stage IV have higher odds of recurrence post-ablation (OR, 4.24; 95% CI, 2.39- 7.52, P < 0.001). Conclusion: This metanalysis demonstrates the strong association between left atrial fibrosis in LGE-MRI and AF post-ablation recurrence. The finding of this study will further assist clinicians in predicting the recurrence rate of AF based on the amount of fibrosis and tailor therapeutic decisions for further management.

27 April 2020 in Clinical Medicine & Research
Verified
Journal Article
Closed access
PDF file
MRManjari Regmi
Manjari Regmi
MBMukul Bhattarai
Mukul Bhattarai
PPPriyanka Parajuli
Priyanka Parajuli
OGOdalys Estefania Lara Garcia
Odalys Estefania Lara Garcia
NTNitin Tandan
Nitin Tandan
RRRobert Robinson
Robert Robinson
Objective: Several studies identify heart failure (HF) as a potential risk for hospital readmission; however, studies on predictability of heart failure readmission is limited. The objective of this work was to investigate whether a specific type of heart failure (HFpEF or HFrEF) has a higher association to the rate of 30-day hospital readmission and compare their predictability with the two risk scores: HOSPITAL score and LACE index. Design: Retrospective study from single academic center. Methods: Sample size included adult patients from an academic hospital in a two-year period (2015 - 2017). Exclusion criteria included death, transfer to another hospital, and unadvised leave from hospital. Baseline characteristics, diagnosis-related group, and ICD diagnosis codes were obtained. Variables affecting HOSPITAL score and LACE index and types of heart failure present were also extracted. Qualitative variables were compared using Pearson chi2 or Fisher’s exact test (reported as frequency) and quantitative variables using non-parametric Mann–Whitney U test (reported as mean ± standard deviation). Variables from univariate analysis with P values of 0.05 or less were further analyzed using multivariate logistic regression. Odds ratio was used to measure potential risk. Results: The sample size of adult patients in the study period was 1,916. All eligible cohort of patients who were readmitted were analyzed. Cumulative score indicators of HOSPITAL Score, LACE index (including the Charlson Comorbidity Index) predicted 30-day readmissions with P values of <0.001. The P value of HFpEF was found to be significant in the readmitted group (P < 0.001) compared to HFrEF (P = 0.141). Multivariate logistic regression further demonstrated the association of HFpEF with higher risk of readmission with odds ratio of 1.77 (95% CI: 1.25 – 2.50) and P value of 0.001. Conclusions: Our data from an academic tertiary care center supports HFpEF as an independent risk factor for readmission. Multidisciplinary management of HFpEF may be an important target for interventions to reduce hospital readmissions.

1 April 2020 in JACC: Case Reports
Verified
Journal Article
Open access
MRManjari Regmi
Manjari Regmi
OGOdalys Estefania Lara Garcia
Odalys Estefania Lara Garcia
PPPriyanka Parajuli
Priyanka Parajuli
OMOswaldo Madrid
Oswaldo Madrid
AHAbdul Moiz Hafiz
Abdul Moiz Hafiz
Late thrombus formation is a rare complication associated with patent foramen ovale (PFO) closure devices. We report the case of an incidental discovery of large thrombi in both atria 9 months after percutaneous PFO occlusion that required cardiac surgery for thrombi removal. (Level of Difficulty: Beginner.)